The ischemia reperfusion injury treatment market is projected to grow from USD 983.9 million in 2025 to USD 1,778.6 million by 2035, at a CAGR of 6.1%. Heart Injury will dominate with a 47.3% market share, while hospitals will lead the end-user segment with a 58.6% share.